Literature DB >> 18603504

Use of compact digital cervicography: an adjuvant screening tool for precancerous cervical lesions.

Zip-Pon Chen1, Hong-Ming Chen, Tim-Tso Lee.   

Abstract

OBJECTIVE: In an attempt to develop a new model to screen for cervical cancer, we set up a digital camera mounted with a macro lens for cervicography. This digitalized compact form of cervicography with the Reid colposcopic index (RCI) can be applied as an adjuvant tool to screen for abnormal Papanicolaou (Pap) smears.
MATERIALS AND METHODS: Among 21,532 cases screened with a Pap smear, we enrolled 125 cases with precancerous smears for this prospective study. An 8-megapixel Canon digital camera with a macro lens and a light source comprised the compact digital cervicographic system. The results of compact digital cervicography were reported using the RCI scoring system. Cases with high-grade squamous intraepithelial lesion or atypical glandular cells of undetermined significance were transferred to medical centers for further confirmation and management. In total, 119 cases underwent compact digital cervicography. The data were analyzed with the McNemar test.
RESULTS: With the digitized results of compact digital cervicography, we were able to show patients with precancerous Pap smears their cervix and help them understand its status. For patients with an abnormal Pap smear, the results of performing compact digital cervicography combined with the RCI scoring system were statistically significant (p < 0.05).
CONCLUSION: The use of compact digital cervicography with the RCI scoring system is a significant device for screening abnormal Pap cases. It helps to improve patient care. Further research is required to understand the discrepancies among diagnostic results of Pap smears (the Bethesda system), cervicography with RCI, and histopathology.

Entities:  

Mesh:

Year:  2008        PMID: 18603504     DOI: 10.1016/S1028-4559(08)60078-9

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  6 in total

1.  eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.

Authors:  Groesbeck P Parham; Mulindi H Mwanahamuntu; Krista S Pfaendler; Vikrant V Sahasrabuddhe; Daniel Myung; Gracilia Mkumba; Sharon Kapambwe; Bianca Mwanza; Carla Chibwesha; Michael L Hicks; Jeffrey S A Stringer
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

Review 2.  The use of optical spectroscopy for in vivo detection of cervical pre-cancer.

Authors:  Sanaz Hariri Tabrizi; S Mahmoud Reza Aghamiri; Farah Farzaneh; Henricus J C M Sterenborg
Journal:  Lasers Med Sci       Date:  2013-03-07       Impact factor: 3.161

3.  Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.

Authors:  Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Meridith Blevins; Sharon Kapambwe; Bryan E Shepherd; Carla Chibwesha; Krista S Pfaendler; Gracilia Mkumba; Belington Vwalika; Michael L Hicks; Sten H Vermund; Jeffrey Sa Stringer; Groesbeck P Parham
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

4.  Development and validation of novel digitalized cervicography system.

Authors:  Soo-Nyung Kim; Yun Hwan Kim; Kye-Hyun Nam; Seon-Kyung Lee; Tae Sung Lee; Ho-Sun Choi; Sei-Jun Han; Seung-Cheol Kim
Journal:  Obstet Gynecol Sci       Date:  2016-05-13

5.  Digital Cervicography by Simply Portable Device as an Alternative Test for Cervical Cancer Screening in Rural Area of Thailand

Authors:  Nissana Singhakum; Somsak Laiwejpithaya; Pattama Chaopotong
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-27

6.  Quantitative Screening of Cervical Cancers for Low-Resource Settings: Pilot Study of Smartphone-Based Endoscopic Visual Inspection After Acetic Acid Using Machine Learning Techniques.

Authors:  Jung Kweon Bae; Hyun-Jin Roh; Joon S You; Kyungbin Kim; Yujin Ahn; Sanzhar Askaruly; Kibeom Park; Hyunmo Yang; Gil-Jin Jang; Kyung Hyun Moon; Woonggyu Jung
Journal:  JMIR Mhealth Uhealth       Date:  2020-03-11       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.